Characterization of two polymorphisms in the leukotriene C4 synthase gene in an Australian population of subjects with mild, moderate, and severe asthma

被引:53
作者
Kedda, MA
Shi, J
Duffy, D
Phelps, S
Yang, I
O'Hara, K
Fong, K
Thompson, PJ
机构
[1] Univ Western Australia, Cooperat Res Ctr Asthma, Perth, WA 6009, Australia
[2] Univ Western Australia, Asthma & Allergy Res Inst Inc, Perth, WA 6009, Australia
[3] Univ Western Australia, Western Australian Inst Med Res, Perth, WA 6009, Australia
[4] Univ Western Australia, Ctr Epidemiol Lab, Perth, WA 6009, Australia
[5] Prince Charles Hosp, Genet Epidemiol Lab, Queensland Inst Med Res, Brisbane, Qld 4032, Australia
[6] Prince Charles Hosp, Thorac Lab, Brisbane, Qld 4032, Australia
关键词
LTC4; synthase; asthma; disease severity; aspirin intolerant; promoter polymorphism; Australian population;
D O I
10.1016/j.jaci.2004.02.008
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: The cysteinyl-leukotrienes (cys-LTs) are proinflammatory mediators that are important in the pathophysiology of asthma. LTC4 synthase is a key enzyme in the cys-LT biosynthetic pathway, and studies in small populations have suggested that a promoter polymorphism (A(-444)C) in the gene might be associated with asthma severity and aspirin intolerance. Objective: We sought to screen the LTC4 synthase gene for polymorphisms and to determine whether there is an association between these polymorphisms and asthma severity or aspirin sensitivity in a large, well-phenotyped population and to determine whether this polymorphism is functionally relevant. Methods: The coding regions of the LTC4 synthase gene were screened for polymorphisms and the A(-444)C polymorphism was analyzed in a large Australian white adult population of mild (n = 282), moderate (n = 236), and severe asthmatic subjects (n = 86) and nonasthmatic subjects (n = 458), as well as in aspirin-intolerant asthmatic subjects (n = 67). The functional activity of the promoter polymorphism was investigated by transient transfection of HL-60 cells with a promoter construct. Results: A new polymorphism was identified in intron 1 of the gene (IVS1-10c>a) but was not associated with asthma. Association studies showed that the A(-444)C polymorphism was weakly associated with asthma per se, but there was no association between the C-444 allele and chronic asthma severity or aspirin intolerance. A meta-analysis of all the genetic studies conducted to date found significant between-study heterogeneity in C-444 allele frequencies within different clinical subgroups. In vitro functional studies showed no significant differences in transcription efficiency between constructs containing the A(-444) allele or the C-444 allele. Conclusions: Our data confirm that, independent of transcriptional activity, the C-444 allele in the LTC4 synthase gene is weakly associated with the asthma phenotype, but it is not related to disease severity or aspirin intolerance.
引用
收藏
页码:889 / 895
页数:7
相关论文
共 34 条
[1]   Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT1 antagonist, pranlukast, in Japanese patients with moderate asthma [J].
Asano, K ;
Shiomi, T ;
Hasegawa, N ;
Nakamura, H ;
Kudo, H ;
Matsuzaki, T ;
Hakuno, H ;
Fukunaga, K ;
Suzuki, Y ;
Kanazawa, M ;
Yamaguchi, K .
PHARMACOGENETICS, 2002, 12 (07) :565-570
[2]   Leukotriene C4 is a tight-binding inhibitor of microsomal glutathione transferase-1 -: Effects of leukotriene pathway modifiers [J].
Bannenberg, G ;
Dahlén, SE ;
Luijerink, M ;
Lundqvist, G ;
Morgenstern, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (04) :1994-1999
[3]   Molecular cloning of the human leukotriene C-4 synthase gene and assignment to chromosome 5q35 [J].
Bigby, TD ;
Hodulik, CR ;
Arden, KC ;
Fu, LX .
MOLECULAR MEDICINE, 1996, 2 (05) :637-646
[4]  
Bleecker ER, 1998, CLIN EXP ALLERGY, V28, P6
[5]  
Brauer JE, 1999, AM J RESP CRIT CARE, V159, pA650
[6]   Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma [J].
Cowburn, AS ;
Sladek, K ;
Soja, J ;
Adamek, L ;
Nizankowska, E ;
Szczeklik, A ;
Lam, BK ;
Penrose, JF ;
Austen, KF ;
Holgate, ST ;
Sampson, AP .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) :834-846
[7]   Candidate gene studies in respiratory disease: avoiding the pitfalls [J].
Hall, I .
THORAX, 2002, 57 (05) :377-378
[8]   Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study [J].
Hedman, J ;
Kaprio, J ;
Poussa, T ;
Nieminen, MM .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1999, 28 (04) :717-722
[9]  
Holgate Stephen T., 2003, Journal of Allergy and Clinical Immunology, V111, pS18, DOI 10.1067/mai.2003.25
[10]   Genetic polymorphisms in lung disease: bandwagon or breakthrough? [J].
Iannuzzi, MC ;
Maliarik, M ;
Rybicki, B .
RESPIRATORY RESEARCH, 2002, 3 (01)